Juan Saavedra (Georgetown University; DC, USA) & Abdel Elkahloun (National Institutes of Health; MD, USA) elaborate on the findings from their recent report in Alzheimer’s Research & Therapy discussing the potential of candesartan as a therapeutic for early Alzheimer’s disease.
Uri Magaram and Sreekanth Chalasani (The Salk Institute for Biological Sciences; CA, USA) discuss their recent work in sonogenetics and consider the potential applications of the emerging technology.
Kristian Doyle (University of Arizona, AZ, USA) discusses the need for develpment of treatments for stroke-related dementia and understanding the pathophysiology associated with chronic stroke lesions.
Andrés Miguez & Jordi Alberch (University of Barcelona, Spain) discuss their exceptional work on the potential efficacy of the Multiple Sclerosis drug, Fingolimod, in treating cognitive deficits in Huntington’s disease.
Deborah Gustafson (State University of New York—Downstate Medical Center, NY, USA & University of Gothenburg, Sweden) discusses the complex relationship between BMI and dementia and evaluates the current literature within the epidemiological literature.
This opinion piece discusses the issues with identification and management of depression in brain tumor patients and recommends best practice within the field.
The 2015 Rugby World Cup has sparked discussions over the control of and education around head injuries within both rugby and other sports. We highlight some of the key focuses of the debate and key recent research articles from the journal Concussion.
Charbel Moussa discusses his exciting work into the use of FDA approved tyrosine kinase inhibitors to clear toxic neuronal proteins via autophagy.
The World Federation of Neurology takes the motto ‘Epilepsy is more than seizures’ for their second World Brain Day.